Search Results

GPCR drug discovery, assay innovation, and translational pharmacology bridging academia, pharma, and biotech Marro’s career spans big pharma and biotech, encompassing functional assay development, GPCR internalization research, and both small molecule and biologic drug discovery. Teams expanding into antibody or biologic modalities for challenging GPCR targets. Scientists seeking practical advice on career pivots between academia, pharma, and biotech.

Berchiche obtained her Master’s and Ph.D. in Biochemistry at the University of Montreal in Canada before expertise over the past two decades studying structure/function relationships of GPCRs using live-cell bioluminescence Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Listeners will gain perspective on how asking broader questions about receptor biology can reshape drug His research spans four decades of GPCR signaling, from cyclic AMP and adrenergic receptor biology to His lab combines bioinformatic analysis of GPCR expression across human cancers with wet-lab validation intersects with cancer, immunology, and systems biology. Paul Insel was at the FASEB experimental biology meeting in Atlantic City.

Slosky was awarded a B.S. with honors in Molecular and Cellular Biology and Psychology from The University Integrating GPCR biology, behavioral pharmacology, and systems neuroscience approaches, the Slosky Lab Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Lukas Grätz "After a BSc in biology and a MSc in bioinformatics, I have been working in David Gloriam's group as a bioinformatician. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

A fungal serine protease allergen with GPCR-modulating features was discovered as a new biomarker and Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Key Takeaways: From Protein Folding to GPCRs – How Dmitry transitioned from biophysics and protein folding Building Z7 Biotech – The unexpected journey into biotech entrepreneurship, providing GPCR profiling services to pharma and biotech companies. Dmitry studied biophysics at the Moscow State University, followed by a PhD (1998) in protein folding He joined the MRC Centre for Protein Engineering and later at the MRC Laboratory of Molecular Biology

Simone Prömel Simone Prömel is currently a professor of cell biology at the Heinrich Heine University Being a biochemist by training, she completed her Ph.D. at the Institute of Biochemistry at the University Liebscher is a Professor at the Rudolf Schönheimer Institute of Biochemistry at the Medical Faculty of Being faced with the vast unknown biochemical and pharmacological territory that would be helpful to Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology & Toxicology’, and in 2021 also named him a Highly Cited Researcher in the additional category of ‘Biology & Biochemistry’. He also discussed the evolution of the field, from biochemical radioligand binding assays to cell-based his experiences in the pharmaceutical industry, highlighting the differences between big pharma and biotech

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology & Toxicology’, and in 2021 also named him a Highly Cited Researcher in the additional category of ‘Biology & Biochemistry’. They also emphasized the significance of fundamental discoveries, the role of biotech, and the need for

Fan is currently an associate professor of Pharmacology and Pathology and Cell Biology at Columbia University Qing is a structural biologist interested in the molecular mechanisms controlling how class C GPCRs transmit Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

He leads a multidisciplinary research team comprising biologists, chemists, physicists, engineers and journals such as Nature, Cell, New England Journal of Medicine, Journal of Clinical Investigation, PLoS Biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Sokhom Pin shares how he built a biotech career around GPCRs, designed a custom PhD path, and led teams From his early work as a technician at Johns Hopkins Hospital to leading biology at Servo Therapeutics He blends classical receptor pharmacology with biosensor technology, always adapting to new tools and Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

For my doctoral studies, I joined the lab of Dr Andreas Russ at the Department of Biochemistry and first recruited to the Medical Faculty of Leipzig University, where I now head the Department of General Biochemistry Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Last summer, Julia worked at as the first-ever summer intern at Septerna, the GPCR-based biotechnology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Schulte is a Professor in receptor pharmacology and research group leader for the section Receptor Biology He has a background in biochemistry from the Free University in Berlin/Germany and a Ph.D. in molecular Melbourne Australia, GPCR pharmacology; 2006) before starting his independent research team "Receptor Biology Molecular Pharmacology, British Journal of Pharmacology, Pharmacological Reviews, and The Journal of Biological is on Frizzled signaling and pharmacology aiming to understand the role of WNT/Frizzled signaling in biology

program in the Department of Pharmaceutical Sciences at the Faculty of Pharmacy and the Department of Biochemistry He is the scientific founder of two biotech companies, ModMab Therapeutics , and AntlerA Therapeutics Angers was named Director of the Donnelly Centre of Cellular and Biomolecular Research at the University Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology Cardarelli is a drug development leader with extensive experience driving drug discovery teams in bringing biologics She has expertise in cell biology, pharmacology, translational medicine, oncology, immuno-oncology, immunology Previously, she held the position of Vice President of Cell Biology & Pharmacology, at Bristol-Myers She has extensive experience working with Biologics, and Antibody Drug Conjugates as well as experience

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

He did B.Sc. in biology at McGill University and received his Ph.D. under the mentorship of Dr. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Michel Bouvier Michel Bouvier is a professor of Biochemistry and Molecular Medicine and the CEO of the In 1989, he returned to Montréal as a professor of biochemistry and a scholar of the Medical Research paradigm shifts including inverse agonism, biased signaling, and pharmacological chaperones, his work on bioluminescence Bouvier Lab Google Scholar Pubmed ResearchGate Twitter LinkedIn Universite de Montreal- Department of Biochemistry Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Bianca Plouffe obtained her B.Sc. in Biochemistry in 2003 from Université de Sherbrooke (Qc, Canada). As part of Bouvier’s team, Bianca used Bioluminescence Resonance Energy Transfer (BRET)-based technology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology